Literature DB >> 27363854

Fetal laser ablation of feeding artery of cystic lung lesions with systemic arterial blood supply.

R Cruz-Martinez1,2, M Martínez-Rodríguez1,2, M Bermúdez-Rojas1, C Magaña-Abarca1, V Narvaez-Dominguez2, A Rojas-Macedo3, N Bautista-García2, M Alcocer-Alcocer2.   

Abstract

OBJECTIVE: To assess the effectiveness of laser surgery in fetuses with a cystic lung lesion with systemic arterial blood supply (hybrid lung lesion) at risk of perinatal death.
METHODS: A cohort of five consecutive fetuses with a large hybrid lung lesion associated with hydrops and/or pleural effusion with severe lung compression was selected for percutaneous ultrasound-guided fetal laser ablation of the feeding artery (FLAFA) before 32 weeks' gestation in a single tertiary national referral center in Queretaro, Mexico. The primary outcomes were survival and need for postnatal surgery.
RESULTS: FLAFA was performed successfully in all cases at a median gestational age of 24.9 (range, 24.4-31.7) weeks. After fetal intervention, dimensions in both lungs increased and fluid effusions resolved in all cases. All cases were delivered liveborn at term at a median gestational age of 39.6 (range, 38.0-39.7) weeks, without respiratory morbidity or need for oxygen support, resulting in perinatal survival of 100%. During follow-up, three (60%) cases showed progressive regression of the entire lung mass and did not require postnatal surgery, whereas in two (40%) cases a progressive decrease in size of the mass was observed but a cystic portion of the lung mass persisted and postnatal lobectomy was required.
CONCLUSION: In fetuses with large hybrid lung lesions at risk of perinatal death, FLAFA is feasible and could improve survival and decrease the need for postnatal surgery.
Copyright © 2016 ISUOG. Published by John Wiley & Sons Ltd. Copyright © 2016 ISUOG. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  bronchopulmonary sequestration; congenital cystic adenomatoid malformation; fetal surgery; hybrid lung lesion; laser therapy

Mesh:

Year:  2017        PMID: 27363854     DOI: 10.1002/uog.16011

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  1 in total

1.  Rare Case of Fetal Permanent Junctional Reciprocating Tachycardia Refractory to Prenatal Antiarrhythmic Therapy.

Authors:  Kavita Narang; Carl H Rose; Jonathan N Johnson; Philip L Wackel; Frank Cetta
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2020-11-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.